2seventy bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of 2seventy bio generated cash of -$166,858,000, which is more than the previous year. Cash used in financing activities reached the amount of $127,390,000 last year. Net change in cash is therefore $4,393,000.
Cash Flow
| 2018 | -146.21M | -50.82M | 197.04M |
|---|---|---|---|
| 2019 | -207.95M | -59.76M | 267.72M |
| 2020 | -67.79M | -22.26M | 90.05M |
| 2021 | -207.03M | 15.41M | 354.88M |
| 2022 | -237.13M | 11.69M | 166.22M |
| 2023 | -166.85M | 43.86M | 127.39M |
TSVT Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 72.29M | 163.26M | 0 | 0 | 0 | 0 |
Operating activities | ||||||
Net income | -217.57M | -254.15M | -292.21M | -120.11M | -320.59M | -199.74M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 10.28M | 11.53M | 16.35M | 13.18M | 12.58M | 13.34M |
Stock-based compensation expense | 32.15M | 41.04M | 54.62M | 60.99M | 62.04M | 0 |
| Deferred income tax benefit | 32.15M | 41.04M | 54.62M | 60.99M | 62.04M | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -423K | 327K | -6K | -13.24M | 14.61M | 2.23M |
Cash generated by operating activities | -166.85M | -237.13M | -207.03M | -67.79M | -207.95M | -146.21M |
Investing activities | ||||||
Purchases Of Investments | -265.17M | -145.90M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -13.86M | -22.84M | -19.57M | -22.26M | -59.76M | -50.82M |
Acquisitions Net | 0 | -34.53M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 43.86M | 11.69M | 15.41M | -22.26M | -59.76M | -50.82M |
Financing activities | ||||||
Common Stock Issued | 126.86M | 165.53M | 6.54M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | -1.01M |
Cash used in financing activities | 127.39M | 166.22M | 354.88M | 90.05M | 267.72M | 197.04M |
Net Change In Cash | 4.39M | -59.20M | 163.26M | 0 | 0 | 0 |
Cash at end of period | 76.68M | 104.05M | 163.26M | 0 | 0 | 0 |
| Data source | Data source | Data source |